From: Challenges of palliative care in children with inborn metabolic diseases
Lysosomal storage diseases | |
Sphingolipidoses | |
• Canavan disease | 1 |
• Krabbe disease | 1 |
• Other | 2 |
Sulfatidoses | |
• Metachromatic leukodystrophy | 3 |
Gangliosidoses | |
• GM2 Gangliosidosis (Tay-Sachs disease) | 1 |
Alexander disease | 2 |
Mucopolysaccharidoses | 2 |
Neuronal ceroid lipofuscinosis | 2 |
Fatty acid disorders | |
• Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency | *1 |
Glycine metabolism disorders | |
• Hyperglycinemia, nonketotic | 2 |
Mitochondrial diseases | |
• Pearson syndrome | *2 |
• Leigh syndrome | *2 |
• EARS2 mutation | *1 |
• TMEM70 mutation | *1 |
• etiology unknown | *4 |
Methionine metabolism disorders | |
• Sulfite oxidase deficiency | *1 |
Cofactor deficiency disorders | |
• Molybdenum cofactor deficiency | *1 |